Hot Features
Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of so... Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardio chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular, and peripheral artery disease (PAD) and ischemic stroke. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.0001 | 0.0001 | 5.0E-5 | 709570 | 0.0001 | CS |
| 4 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 619094 | 9.947E-5 | CS |
| 12 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 1548629 | 7.849E-5 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 2250825 | 9.166E-5 | CS |
| 52 | 0 | 0 | 0.0001 | 0.0003 | 1.0E-6 | 7443724 | 0.00011541 | CS |
| 156 | -0.0146 | -99.3197278912 | 0.0147 | 0.0178 | 1.0E-6 | 6712391 | 0.00040598 | CS |
| 260 | -0.0304 | -99.6721311475 | 0.0305 | 0.06 | 1.0E-6 | 3943402 | 0.00091697 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.